Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-01-08
2008-01-08
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S116000, C544S235000, C514S248000
Reexamination Certificate
active
11500293
ABSTRACT:
The invention relates to compound of the formula (I) or its salt, in which R1, R2, R3and R4are as defined in the description, their use of as medicament, the process for their preparation and use for the treatment of PDE-IV or TNF-α mediated diseases
REFERENCES:
patent: 6472389 (2002-10-01), Ohtani et al.
patent: 2 792 938 (2000-11-01), None
patent: WO 91/18903 (1991-12-01), None
patent: WO 9118903 (1991-12-01), None
patent: 03/082208 (2003-10-01), None
Cecil Textbook of Medicine (20th Edition, vol. 2), 1996, pp. 1739-1747.
Aoki et al. The Journal of Pharmacology and Experimental Therapeutics, vol. 298, No. 3, pp. 1142-1149.
Duan et al. (abstract of Chin J. Hepatol., Aug. 2003, vol. 11, No. 8, 493-496).
Ichiyama et al, Scand. J. Infect. Dis., 35:59-61 (2003).
Kawada et al, J. Infect. Dis. 2003, 188(5): 690-698).
Landellls et al. British Journal of Pharmacology (2001) 133, 722-729.
W. Flitsch, et al., Tetrahedron Letters, vol. 12, XP-002273465, pp. 1479-1484, “Synthesen und Reaktionen von 5-Aza-Indolizinen und 5-Aza-Cycl(3.2.2)Azin-Derivaten”, 1968.
Cecil Textbook of Medicine (20thEdition, vol. 2), 1996, pp. 1739-1747.
Flitsch et al. Tetrahedron Letters (1968), (12), 1479-84.
Takashi Ichiyama, et al., “Cerebrospinal Fluid and Serum Levels of Cytokines and Soluble Tumor Necrosis Factor Receptor Influenza Virus-associated Enciphalopathy”, Scand J Infect Dis, Taylor & Francis Healthsciences, vol. 35, pp. 59-61.
Jun-Ichi Kawada, et al., “Systemic Cytokine Responses in Patients with Influenza-Associated Enciphalopathy”, Major Article, Sep. 1, 2003, pp. 690-698.
Duan Zhong-Ping, et al., “Clinical Characteristics and Mechanism of Liver Injury in Patients with Severe Acute Respiratory Syndrome”, Chin J. Hepatol, vol. 11, No. 8, Aug. 2003, pp. 493-496.
Landellls et al., British Journal of Pharmacology (2001) 133, 722-729.
STN Search Printout (p. 66-70), from wo 91/18903, 1991.
Mark Glembycz, Current Opinion in Pharmacology, 2005, 5:238-244.
Abe Yoshito
Imamura Kenichiro
Inoue Makoto
Mizutani Tsuyoshi
Ohne Kazuhiko
Astellas Pharma Inc.
Habte Kahsay
LandOfFree
Pyrrolopyridazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolopyridazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyridazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3937648